Add like
Add dislike
Add to saved papers

[Treatment Outcome of Intersphincteric Resection in Tokyo Medical University Hospital].

PURPOSE: This study aimed to consider the oncological validity of intersphincteric resection(hereinafter referred to as ISR) performed at Tokyo Medical University Hospital, as well as associated dysfunction.

SUBJECTS: Subjects included 73 cases in which ISR was performed at Tokyo Medical University Hospital between November 2004 and January 2016.

RESULTS: The 5- year overall and relapse-free survival rates for cases with Stage 0 to III were 90.4% and 77.3%, respectively. Two cases with recurrence among cases with Stage I were both of local recurrence.The Wexner score of the cases 12 months after closure of ileostomy was 4.2±2.5 points, while it had not been performed for the other 10 cases.

DISCUSSION: In consideration of the relatively preferable local control observed with ISRs that had been performed at our hospital, defecation disorder was considered to be within an allowance.However, there remained a problem that closure of ileostomy could not be performed for 10% of the cases.

CONCLUSION: ISR was believed to be valid as a sphincter-preserving procedure in consideration of the function and curability.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app